BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32143898)

  • 1. Epidemiological trend of hepatitis C-related liver events in Spain (2000-2015): A nationwide population-based study.
    Mate-Cano I; Alvaro-Meca A; Ryan P; Resino S; Briz V
    Eur J Intern Med; 2020 May; 75():84-92. PubMed ID: 32143898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.
    Kim D; Cholankeril G; Li AA; Kim W; Tighe SP; Hameed B; Kwo PY; Harrison SA; Younossi ZM; Ahmed A
    Liver Int; 2019 Sep; 39(9):1661-1671. PubMed ID: 31081997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological Trend of Sepsis in Patients with Hospital Admissions Related to Hepatitis C in Spain (2000-2015): A Nationwide Study.
    Alvaro-Meca A; Maté-Cano I; Ryan P; Briz V; Resino S
    J Clin Med; 2020 May; 9(6):. PubMed ID: 32466412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C and hepatitis B-related mortality in Spain.
    García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
    Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data linkage to monitor hepatitis C-associated end-stage liver disease and hepatocellular carcinoma inpatient stays in England.
    Ireland G; Simmons R; Hickman M; Harris R; Ramsay M; Sabin C; Mandal S
    J Viral Hepat; 2020 Jan; 27(1):20-27. PubMed ID: 31505083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and predictors of outcomes after surgery for hepatocellular carcinoma: A nationwide population-based study in Taiwan.
    Chiu CC; Wang JJ; Chen YS; Chen JJ; Tsai TC; Lai CC; Sun DP; Shi HY
    Eur J Surg Oncol; 2015 Sep; 41(9):1170-8. PubMed ID: 26048295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?
    Goodgame B; Shaheen NJ; Galanko J; El-Serag HB
    Am J Gastroenterol; 2003 Nov; 98(11):2535-42. PubMed ID: 14638360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study).
    Abergel A; Rotily M; Branchoux S; Akremi R; de Léotoing L; Vainchtock A; Gaudin AF
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):340-348. PubMed ID: 26546175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-related mortality among people with hepatitis B and C: Evaluation of definitions based on linked healthcare administrative datasets.
    Shah SHBU; Alavi M; Hajarizadeh B; Matthews G; Valerio H; Dore GJ
    J Viral Hepat; 2023 Jun; 30(6):520-529. PubMed ID: 36843500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection.
    Gordon SC; Pockros PJ; Terrault NA; Hoop RS; Buikema A; Nerenz D; Hamzeh FM
    Hepatology; 2012 Nov; 56(5):1651-60. PubMed ID: 22610658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil.
    Kikuchi L; Chagas AL; Alencar RS; Paranaguá-Vezozzo DC; Carrilho FJ
    Antivir Ther; 2013; 18(3 Pt B):445-9. PubMed ID: 23793796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
    Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.
    Chiang CJ; Yang YW; Chen JD; You SL; Yang HI; Lee MH; Lai MS; Chen CJ
    Hepatology; 2015 Apr; 61(4):1154-62. PubMed ID: 25476749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological trends of deep venous thrombosis in HIV-infected subjects (1997-2013): A nationwide population-based study in Spain.
    Alvaro-Meca A; Ryan P; Martínez-Larrull E; Micheloud D; Berenguer J; Resino S
    Eur J Intern Med; 2018 Feb; 48():69-74. PubMed ID: 29102088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    J Viral Hepat; 2016 Sep; 23(9):687-96. PubMed ID: 27040447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.
    Huang YW; Wang TC; Yang SS; Lin SY; Fu SC; Hu JT; Liu CJ; Kao JH; Chen DS
    Aliment Pharmacol Ther; 2015 Oct; 42(7):902-11. PubMed ID: 26211742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.
    Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P
    Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.